Gastrointestinal Oncology

Hardcover | October 29, 2003

EditorJames L. Abbruzzese, Douglas B. Evans, Christopher G. Willett

not yet rated|write a review
In 74 chapters, Gastrointestinal Oncology brings together a diverse group of specialists to provide the most authoritative, up-to-date and encyclopedic volume currently available on the subject. The first part of this text introduces a series of concepts and topics taht are important togastrointestinal malignancies in general. These topics include epidemiologic principles, prevention, screening, familial GI cancers, developmental and molecular biology, pathobiology, general therapeutic principles, emerging therapies, and palliative care. The second part of the book covers eachof the specific cancers affecting the human gastrointestinal tract. These chapters are introduced by state of the art discussions outlining our current understanding of the pathobiology and molecular biology relevant to each cancer. Subsequent sections describe the multidisciplinary management ofspecific clinical situations. By organizing the treatment-related chapters around clinical scenarios, the reader will readily find the information necessary to effectively manage the complex clinical situations encountered by patients with gastrointestinal malignancies.

Pricing and Purchase Info

$269.50

Ships within 1-3 weeks
Ships free on orders over $25

From the Publisher

In 74 chapters, Gastrointestinal Oncology brings together a diverse group of specialists to provide the most authoritative, up-to-date and encyclopedic volume currently available on the subject. The first part of this text introduces a series of concepts and topics taht are important togastrointestinal malignancies in general. These ...

Douglas B. Evans is at both at University of Texas M.D Anderson Cancer Center.

other books by James L. Abbruzzese

The Fever Code (maze Runner, Book Five; Prequel)
The Fever Code (maze Runner, Book Five; Prequel)

Hardcover|Sep 27 2016

$14.51 online$24.99list price(save 41%)
Catalyst (star Wars): A Rogue One Novel
Catalyst (star Wars): A Rogue One Novel

Hardcover|Nov 15 2016

$22.60 online$37.00list price(save 38%)
Cross The Line
Cross The Line

Hardcover|Nov 21 2016

$29.30 online$38.00list price(save 22%)
see all books by James L. Abbruzzese
Format:HardcoverDimensions:948 pages, 8.82 × 11.3 × 1.69 inPublished:October 29, 2003Publisher:Oxford University PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0195133722

ISBN - 13:9780195133721

Look for similar items by category:

Customer Reviews of Gastrointestinal Oncology

Reviews

Extra Content

Table of Contents

Part I - General Principles1. Christopher I. Amos, PhD and Margaret R. Spitz, MD, MPH: Epidemiological Principles for the Study of Gastrointestinal Cancers2. Imad Shureiqi, MD, Pavan Reddy, MD, Mack T. Ruffin, IV, MD, MPH, and Dean E. Brenner, MD: Prevention and Screening Principles Relevant to Gastrointestinal Malignancies3. Patrick M. Lynch, JD, MD: The Role of Inheritance in the Diagnosis and Management of Gastrointestinal Malignancies4. Mark W. Babyatksy: The Developmental Biology of the Gastrointestinal Tract5. Cecelia Fenoglio-Presier, MD: General Pathobiological Features of Gastrointestinal Neoplasia6. David L. Smith, MD and Douglas Evans, MD: Therapeutic Principles of Gastrointestinal Neoplasia: Surgery7. Ira J. Spiro, MD, PhD and Christopher G. Willett, MD: Therapeutic Principles of Gastrointestinal Neoplasia: Radiation Oncology8. Henry Q. Xiong, MD and James L. Abbruzzese, MD, FACP: Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Vaccines9. J. Milburn Jessup, MD: Theraprutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Vaccines10. Richard J. Aspinall, MB, BS, MRCP and Nicholas R. Lemoine, MD, PhD, FRCPath: Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Gene Therapy11. Paulo M. Hoff, MD, James L. Abbruzzese, MD, FACP, and James Pluda, MD: Therapeutic Principles of Gastrointestinal Neoplasia: Emerging Therapies: Antiangiogenic and Antimetastatic AgentsPart II - Management of Specific Neoplasms1. Cancer of the Esophagus12. Regianld V.N. Lord, FRACS and Peter V. Danenberg, PhD: Epidemiology and Molecular Epidemiology of Esophageal Cancer13. Chris Tselepis, PhD and Janusz Janikowski, MD, PhD, FRCP (Edin): Molecular Biology of Esophageal Cancer14. Jonathan Glickman, MD, PhD and Robert D. Odze, MD, FRCPC: Pathology and Natural History of Esophageal Cancer15. Mark J. Krasna, MD, FCCP, FACS and Xiolong Jiao, MD: Clinical Aspects and Management of Esophageal Carcinoma: Diagnostic and Stagig Procedures16. Joe B. Putnam, Jr. MD: Clinical Aspects and Management of Esophageal Carcinoma: Management Options: Potentially Rescectable Esophageal Cancer a. Surgical Techniques and Results of Resection and Reconstruction b. Combined Modality Therapy - Preoperative Neoadjuvant Therapies - PostoperativeAdjuvant Therapies17. William Small, Jr., MD Mark D. Talamonti, MD, and Al B. Benson, III, MD, FACP: Clinical Aspects and Management of Esophageal Carcinoma: Management Options: Therapy of Metastatic Carcinoma of the Esophagus and Gastroesophageal Junction18. Jaffer A. Ajani, MD and George R. Blumenschein, MD: Clinical Aspects and Management of Esophageal Carcinoma: Management Options: Therapy of Metastatic Carcinoma of the Esophagus and Gastroesophageal Junction19. Thomas G. Paulson, PhD and Brian J. Reid, PhD, MD: Barrett's Esophagus: Molecular Biology and Pathobiology of Barrett's Esophagus20. Stuart Jon Spechler, MD: Barrett's Esophagus: Clinical Aspects and Management2. Cancer of the Stomach21. Steven F. Moss, MD, MRCP and Haim Shirin, MD: Epidemiology and Molecular Epidemiology of Gastric Cancer22. Eiichi Tahara, MD, PhD, FRCPath: Molecular Biology of Gastric Cancer23. Cecelia GFenoglio-Preiser, MD, Amy Noffsinger, MD, and Grant Stemmermann, MD: Pathology and Natural History of Gastric Cancer24. Irving Waxman, MD and Kiranpreet S. Parmar, MD: Clinical Aspects and Management of Gastric Carcinoma: Diagnostic and Staging Procedures - CT, EGD, EUS, etc.25. Paul F. Mansfield, MD: Clinical Aspects and Management of Gastric Carcinoma: Management Options: Potentially Resectable Gasric Cancer a. Surgical Techniques for Resection and Reconstruction b. Combined Modality Therapy - Preoperative Neoadjuvant Therapies - Postoperative Neoadjavant Therapies26. Jeffrey W. Clark, MD: Locally Advanced Unresectable Gastric Cancer a. Role of Palliative Surgery b. Role of Palliative Chemotherapy, Radiation Therapy, and Combinations27. Matthew H. Kulke, MD and Robert J. Mayer, MD: Management Options: Metastatic Gastric Carcinoma3. Cancer of the Pancreas28. Donghui Li, PhD: Epidemiology and Molecular Epidemiology of Pancreatic Cancer29. Marina E. Jean, MD, Andrew M. Lowy, MD, Douglas B. Evans, and Paul J. Chiao, PhD: Molecular Biology of Pancreatic Adenocarcinoma30. George Mutema, MD, PhD and Cecelia Fenoglio-Presier, MD: Pathology and Natural History of Pancreatic Cancer31. Chusilp Charnsangavej, MD and Sandeep Lahoti, MD: Clinical Aspects and Management of Pancreatic Adenocarcinoma: Management Options: Potentially Resectable Pancreatic Cancer32. Eddie K. Abdalla, MD, Peter W.T. Pisters, MD, FACS, and Douglas Evans, MD, FACS: Clinical Aspects and Management of Pancreatic Adenocarcnoma: Management Options: Potentially Resectable Pancreatic Cancer33. Margaret A. Tempero, MD, Paula Termuhlen, MD, Randall E. Brand, MD, and Cornelius Mc Ginn, MD: Clinical Aspects and Management of Pancreatic Adenocarcinoma: Management Options: Locally Advanced Unresectable Pancreatic Cancer34. Mace L. Rothenberg, MD and Jordan D. Berlin, MD: Clinical Aspects and Management of Metastatic Pancreatic CancerCancer of the Bile Ducts and Gallbladder35. Roger D. Soloway, MD and Rayburn Rego, MD: Epidemiology, Molecular Epidemiology and Biomarkers of Biliary Tract Cancers36. Michael Goggins, MD, MRCPI: Molecular Biology of Cholangiocarcinoma and Gallbladder Carcinoma37. Asif Rashid, MBBS, PhD: Pathology and Natural History of Cholangiocarcinoma and Gallbladder Carcinoma38. Isaac Raijman, MD: Clinical Aspects and Management of Cholangiocarcinoma and Gallbladder Carcinoma: Diagnostic and Staging Procedures39. Steven A. Curley, MD, FACS: Clinical Aspects and Management of Cholangiocarcinoma and Gallbladder Carcinoma: Potentially Resectable Gallbladder Carcinoma or Cholangiocarcinoma40. Mark S. Roh, MD and Christopher Johnnides, MD: Clinical Aspects and Management of Cholangiocarcinoma and Gallbladder Carcinoma: Unresectable Gallbladder Carcinoma and Cholangiocarcinoma: Management OptionsHeptocellular Cancer41. Manal M. Hassan, MD, MPH, PhD and Yehuda Z. Patt, MD: Epidemiology and Molecular Epidemiology of Hepatocellular Cancer42. Joe W. Grisham, MD: Molecular Biology of Hepatocellular Cancer43. Ulysses J. Balis, MD and Gregory Y. Lauwers, MD: Pathology and Natural History of Hepatocellular Carcinoma44. Michael A. Choti, MD: Clinical Aspects and Management of Hepatocellular Cancer: Management Options: Potentially Resectable Hepatocellular Cancer: Diagnostic and Staging Procedures45. Mark S. Roh, MD and Jason Robke, MD: Clinical Aspects and Management of Hepatocellular Cancer: Management Options: Potentially Resectable Hepatocellular Carcinoma46. Yehuda Z. Patt, MD and Manal H. Hassan, MD MPH, PhD: Clinical Aspects and Management of Hepatocellular Cancer: Management Options: Metastatic Hepatocellular CarcinomaCancer of the Small Bowel and Appendix47. Alfred I. Neugut, MD, PhD and Nadir Arber, MD: Epidemiology, Molecular Epidemiology, and Molecular Biology of Small Bowel and Appendiceal Adenocarcinomas48. Norman J. Carr, FRCPath and Leslie H. Sobin, MD: Pathology and Natural History of Small Bowel and Appendiceal Cancers49. Karen M. Horton, MD and Elliot K. Fishman, MD: Clinical Aspects and Management of Small Bowel and Appendiceal Cancers: Diagnostic and Staging Procedures50. Larissa K.F. Temple, MD, MSc, FRCS(C) and Daniel G. Coit, MD, FACS: Clinical Aspects and Management of Small-Bowel and Appendiceal Cancers: Management Options: Potentially Resectable Small-Bowel or Appendiceal Carcinomas51. Matthew H. Kulke, MD and Charles S. Fuchs, MD: Clinical Aspects and Management of Small Bowel and Appendiceal Cancers: Management Options: Unresectable, Locally Advanced and Metastatic Small Bowel and Appendiceal Carcinomas7. Cancer of the Colorectum52. Ernest T. Hawk, MD, MPH, Jaye L. Viner, MD, and Paul J. Limberg, MD, MPH: Epidemiology and Prevention of Colorectal Cancer53. Li-Kuo Su, PhD: Molecular Biology of Colorectal Cancer54. Thomas C. Smyrk, MD and Henry T. Lynch, MD: Familial Colorectal Cancer Syndromes55. Grant N. Stemmermann, MD and Cecelia Fenoglio-Preiser, MD: Pathology and Natural History of Colorectal Cancer56. Robert R. Cima, MD and Ronald Bleday, MD: Clinical Aspects and Management of Colon Adenocarcinoma: Diagnostic and Staging Procedures57. Jose G. Guillem, MD and Leonard B. Saltz, MD: Clinical Aspects and Management of Colon Adenocarcinoma: Management Options: Management of Local and Local-Regional Colon Cancer58. Sandeep Lahoti, MD: Clinical Aspects and Management of Rectal Adenocarcinoma: Diagnostic and Staging Prodecures59. Geoffrey A. Porter, MD and John M. Skibber, MD: Clinical Aspects and Management of Rectal Adenocarcinoma: Management Options: Resectable Rectal Carcinoma a. Surgical Approach and Techniques b. Adjuvant Therapy c. Neoadjuvant Therapy60. Bruce D. Minsky, MD: Clinical Aspects and Management of Rectal Adenocarcinoma: Management Options: Unresectable Rectal Carcinoma61. Jean-Nicholas Vauthey, MD, FACS, Diana Medgyesy, MD, John R. Gofin, MD, Melanie Royce, MD, Jean-Pierre Ayoub, MD, and Paolo M. Hoff, MD: Management Options: Metastatic Colorectal Carcinoma: a. Surgical Approach and Techniques b. Regional Therapy c. Systemic Therapy8. Cancer of the Anus62. S. Nicholas Agoff, MD and Nancy B. Kiviat, MD: Pathology, Molecular Biology, and Natural History of Anal Cancer63. Laurie E. Gaspar, MD, Wilson Mertens, MD, David Raben, MD, Scott J. Evans, MD: Clinical Aspects and Management of Anal Cancer9. Neuroendocrine Cancers of the Gastrointestinal Tract64. James C. Yao, MD and Jaffer A. Ajani, MD: Management of Neuroendocrine Cancers of the Gastrointestinal Tract: Carcinoid Tumors65. Ana Oliveria Hoff, MD, Gilbert J. Cote, PhD, and Robert F. Gagel MD: Management of Neuroendocrine Cancers of the GI Tract: Islet Cell Carcinoma of the Pancreas and Other Neuroendocrine Carcinomas10.Lymphomas of the Gastrointestinal Tract66. Antonia R. Sepulveda, MD, PhD: Mucosa-Associated Lymphoid Tissue Lymphomas67. Fernando Cabanillas, MD and Barbara Pro, MD: Low-and-High-Grade Lymphomas11. Sarcomas of the Gastrointestinal Tract68. Malcolm M. Bilimoria, MD, Russell S. Berman, MD, and Raphael E. Pollock, MD, PhD: Epidemiology, Pathology, Molecular Biology, and Natural History of Gastrointestinal Sarcomas69. Janice N. Cormier, MD and Peter W.T. Pisters, MD, FACS: Clinical Aspects and Management of Gastrointestinal Sarcomas: Management Options: Potentially Resectable Gastrointestinal Sarcomas70. Shreyaskumar R. Patel, MD and Robert S. Benjamin, MD: Clinical Aspects and Management of Gastrointestinal Sarcomas: Management Options: Unresectable or Metastatic Gastrointestinal SarcomasPart III - Palliative Care of Patients with Gastrointestinal Malignancy71. Florian Strasser, MD and Eduardo Bruera, MD: Nutritional Support of Patients with Gastrointestinal Malignancies72. Andrew Q. Giap, MD and Kenneth J. Chang, MD: Management of Obstructive Complications: Upper Gastrointestinal Tract: Esophagus, Stomach, and Biliary Tree73. Yasser Al-Antably, MD and Sandeep Lahoti, MD: Management of Obstructive Complications of Lower Gastrointestinal Tract: Colon and Rectum74. Ahmed Elsayem, MD and Eduardo Bruera, MD: Pain Management

Editorial Reviews

"This book offers an excellent source of information on all aspects of malignancies of the gastrointestinal tract, pancreas, and hepatobiliary system. Its organization allows for easy use and applicability to every day clinical practice."--Doody's